Rizatriptan Benzoate recalls

The FDA has published 8 recalls involving Rizatriptan Benzoate since 2021. The latest was reported on 23 Jul 2025. Most were for nitrosamine impurity. Glenmark Pharmaceuticals Inc., U has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls8since 2021
Last 12 months0reported
Class I00% of total
Ongoing6latest 23 Jul 2025

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 6 75%Class III 2 25%

Why rizatriptan benzoate is recalled

By year

Ongoing rizatriptan benzoate recalls

6 active

All rizatriptan benzoate recalls, newest first

8 total

Should you stop taking Rizatriptan Benzoate?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.